Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Br J Pharmacol ; 154(8): 1672-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18552882

ABSTRACT

BACKGROUND AND PURPOSE: Chronic inflammatory conditions, such as granulomas, are associated with angiogenesis. Mast cells represent the main cell type orchestrating angiogenesis, through the release of their granule content. Therefore, compounds able to modulate mast cell behaviour may be considered as a new pharmacological approach to treat angiogenesis-dependent events. Here, we tested the effect of selective cannabinoid (CB) receptor agonists in a model of angiogenesis-dependent granuloma formation induced by lambda-carrageenin in rats. EXPERIMENTAL APPROACH: Granulomas were induced by lambda-carrageenin-soaked sponges implanted subcutaneously on the back of male Wistar rats. After 96 h, implants were removed and granuloma formation was measured (wet weight); angiogenesis was evaluated by histological analysis and by the measurement of haemoglobin content. Mast cells in the granulomas were evaluated histologically and by RT-PCR and immunoblotting analysis for mast cell-derived proteins (rat mast cell protease-5 (rMCP-5) and nerve growth factor). Selective CB1 and CB2 receptor agonists(,) ACEA and JWH-015 (0.001-0.1 mg mL(-1)), were given locally only once, at the time of implantation. KEY RESULTS: The CB1 and CB2 receptor agonists decreased the weight and vascularization of granulomas after 96 h. This treatment also reduced mast cell number and activation in granulomatous tissue. Specifically, these compounds prevented the transcription and expression of rMCP-5, a protein involved in sprouting and advance of new blood vessels. CONCLUSION AND IMPLICATIONS: Modulation of mast cell function by cannabinoids reduced granuloma formation and associated angiogenesis. Therefore cannabinoid-related drugs may be useful in the management of granulomatous diseases accompanied by angiogenesis.


Subject(s)
Arachidonic Acids/pharmacology , Granuloma/pathology , Indoles/pharmacology , Neovascularization, Pathologic/drug therapy , Animals , Arachidonic Acids/administration & dosage , Carrageenan , Chymases/drug effects , Chymases/metabolism , Dose-Response Relationship, Drug , Gene Expression Regulation, Enzymologic/drug effects , Indoles/administration & dosage , Male , Mast Cells/drug effects , Mast Cells/metabolism , Rats , Rats, Wistar , Receptor, Cannabinoid, CB1/agonists , Receptor, Cannabinoid, CB2/agonists , Transcription, Genetic/drug effects
2.
J Biol Chem ; 275(47): 36708-12, 2000 Nov 24.
Article in English | MEDLINE | ID: mdl-10978328

ABSTRACT

The role of iron-dependent oxidative metabolism in protecting the oxidable substrates contained in mature adipocytes is still unclear. Because differentiation increases ferritin formation in several cell types, thereby leading to an accumulation of H-rich isoferritins, we investigated whether differentiation affects iron metabolism in 3T3-L1 pre-adipocytes. To this aim, we evaluated the expression of the genes coding for the H and L ferritin subunits and for cytoplasmic iron regulatory protein (IRP) during the differentiation of 3T3-L1 cells in adipocytes induced by the addition of isobutylmethylxanthine, insulin, and dexamethasone. Differentiation enhanced ferritin formation and caused overexpression of the H subunit, thus altering the H/L subunit ratio. Northern blot analysis showed increased levels of H subunit mRNA. A gel retardation assay of cytoplasmic extract from differentiated cells, using an iron-responsive element as a probe, revealed enhanced an RNA binding capacity of IRP1, which correlated with the increase of IRP1 mRNA. The observed correlation between differentiation and iron metabolism in adipocytes suggests that an accumulation of H-rich isoferritin may limit the toxicity of iron in adipose tissue, thus exerting an antioxidant function.


Subject(s)
Adipocytes/cytology , Cytokines/biosynthesis , Ferritins/biosynthesis , Iron-Sulfur Proteins/genetics , RNA-Binding Proteins/genetics , 3T3 Cells , Animals , Blotting, Northern , Cell Differentiation/genetics , Electrophoresis, Polyacrylamide Gel , Iron Regulatory Protein 1 , Iron-Regulatory Proteins , Iron-Sulfur Proteins/biosynthesis , Mice , RNA, Messenger/metabolism , RNA-Binding Proteins/biosynthesis , Up-Regulation
3.
Biochemistry ; 39(35): 10812-22, 2000 Sep 05.
Article in English | MEDLINE | ID: mdl-10978167

ABSTRACT

Protease-activated receptors (PARs) mediate cell activation after proteolytic cleavage of their extracellular amino terminus. Thrombin selectively cleaves PAR1, PAR3, and PAR4 to induce activation of platelets and vascular cells, while PAR2 is preferentially cleaved by trypsin. In pathological situations, other proteolytic enzymes may be generated in the circulation and could modify the responses of PARs by cleaving their extracellular domains. To assess the ability of such proteases to activate or inactivate PARs, we designed a strategy for locating cleavage sites on the exofacial NH(2)-terminal fragments of the receptors. The first extracellular segments of PAR1 (PAR1E) and PAR2 (PAR2E) expressed as recombinant proteins in Escherichia coli were incubated with a series of proteases likely to be encountered in the circulation during thrombosis or inflammation. Kinetic and dose-response studies were performed, and the cleavage products were analyzed by MALDI-TOF mass spectrometry. Thrombin cleaved PAR1E at the Arg41-Ser42 activation site at concentrations known to induce cellular activation, supporting a native conformation of the recombinant polypeptide. Plasmin, calpain and leukocyte elastase, cathepsin G, and proteinase 3 cleaved at multiple sites and would be expected to disable PAR1 by cleaving COOH-terminal to the activation site. Cleavage specificities were further confirmed using activation site defective PAR1E S42P mutant polypeptides. Surface plasmon resonance studies on immobilized PAR1E or PAR1E S42P were consistent with cleavage results obtained in solution and allowed us to determine affinities of PAR1E-thrombin binding. FACS analyses of intact platelets confirmed the cleavage of PAR1 downstream of the Arg41-Ser42 site. Mass spectrometry studies of PAR2E predicted activation of PAR2 by trypsin through cleavage at the Arg36-Ser37 site, no effect of thrombin, and inactivation of the receptor by plasmin, calpain and leukocyte elastase, cathepsin G, and proteinase 3. The inhibitory effect of elastase was confirmed on native PAR1 and PAR2 on the basis of Ca(2+) signaling studies in endothelial cells. It was concluded that none of the main proteases generated during fibrinolysis or inflammation appears to be able to signal through PAR1 or PAR2. This strategy provides results which can be extended to the native receptor to predict its activation or inactivation, and it could likewise be used to study other PARs or protease-dependent processes.


Subject(s)
Endopeptidases/metabolism , Receptors, Thrombin/antagonists & inhibitors , Receptors, Thrombin/metabolism , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/metabolism , Amino Acid Sequence , Blood Platelets/metabolism , Calcium Signaling , Cell Line , Chromatography, High Pressure Liquid , Chromatography, Liquid , Escherichia coli/genetics , Flow Cytometry , Humans , Hydrolysis , Mass Spectrometry , Molecular Sequence Data , Pancreatic Elastase/physiology , Peptide Fragments/biosynthesis , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Structure, Tertiary/genetics , Receptor, PAR-1 , Receptor, PAR-2 , Receptors, Thrombin/chemistry , Receptors, Thrombin/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Surface Plasmon Resonance , Thrombin/agonists , Thrombin/metabolism , Trypsin/metabolism
4.
Biochem J ; 348 Pt 2: 315-20, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10816424

ABSTRACT

We investigated the effect of oxalomalate (OMA, alpha-hydroxy-beta-oxalosuccinic acid), a competitive inhibitor of aconitase, on the RNA-binding activity of the iron-regulatory proteins (IRP1 and IRP2) that control the post-transcriptional expression of various proteins involved in iron metabolism. The RNA-binding activity of IRP was evaluated by electrophoretic mobility-shift assay of cell lysates from 3T3-L1 mouse fibroblasts, SH-SY5Y human cells and mouse livers incubated in vitro with OMA, with and without 2-mercaptoethanol (2-ME). Analogous experiments were performed in vivo by prolonged incubation (72 h) of 3T3-L1 cells with OMA, and by injecting young mice with equimolar concentrations of oxaloacetate and glyoxylate, which are the precursors of OMA synthesis. OMA remarkably decreased the binding activity of IRP1 and, when present, of IRP2, in all samples analysed. In addition, the recovery of IRP1 by 2-ME in the presence of OMA was constantly lower versus control values. These findings suggest that the severe decrease in IRP1 RNA-binding activity depends on: (i) linking of OMA to the active site of aconitase, which prevents the switch to IRP1 and explains resistance to the reducing agents, and (ii) possible interaction of OMA with some functional amino acid residues in IRP that are responsible for binding to the specific mRNA sequences involved in the regulation of iron metabolism.


Subject(s)
Aconitate Hydratase/antagonists & inhibitors , Iron-Sulfur Proteins/metabolism , Liver/metabolism , Oxalates/pharmacology , RNA-Binding Proteins/metabolism , 3T3 Cells , Animals , Cytosol/enzymology , Enzyme Inhibitors/pharmacology , Glyoxylates/pharmacology , Humans , Iron Regulatory Protein 1 , Iron Regulatory Protein 2 , Iron-Regulatory Proteins , Iron-Sulfur Proteins/drug effects , Kinetics , Mercaptoethanol/pharmacology , Mice , Oxaloacetic Acid/pharmacology , Protein Isoforms/drug effects , Protein Isoforms/metabolism , RNA-Binding Proteins/drug effects , Tumor Cells, Cultured
5.
Biochim Biophys Acta ; 1451(1): 173-86, 1999 Aug 12.
Article in English | MEDLINE | ID: mdl-10446399

ABSTRACT

We produced recombinant human thrombin mutants to investigate the correlation between the thrombin enzyme and mitogenic activity. Single amino acid substitutions were introduced in the catalytic triad (H43N, D99N, S205A, S205T), in the oxy-anion binding site (G203A) and in the anion binding exosite-1 region (R73E). Proteins were produced as prethrombin-2 mutants secreted in the culture medium of DXB11-derived cell lines. All mutants were activated by ecarin to the corresponding thrombin mutants; the enzymatic activity was assayed on a chromogenic substrate and on the procoagulant substrate fibrinogen. Mutations S205A and G203A completely abolished the enzyme activity. Mutations H43N, D99N and S205T dramatically impaired the enzyme activity toward both substrates. The R73E mutation dissociated the amidolytic activity and the clotting activity of the protein. The ability of thrombin mutants to induce proliferation was investigated in NIH3T3 mouse fibroblasts and rat cortical astrocytes. The ability of the thrombin mutants to revert astrocyte stellation was also studied. The mitogenic activity and the effect on the astrocyte stellation of the thrombin mutants correlated with their enzymatic activity. Furthermore the receptor occupancy by the inactive S205A mutant prevented the thrombin effects providing strong evidence that a proteolytically activated receptor is involved in cellular responses to thrombin.


Subject(s)
Astrocytes/drug effects , Enzyme Precursors/genetics , Mitogens/genetics , Prothrombin/genetics , Thrombin/genetics , 3T3 Cells , Animals , Astrocytes/metabolism , Astrocytes/physiology , Blood Coagulation/drug effects , Bucladesine/pharmacology , Cell Differentiation , Cells, Cultured , Chromogenic Compounds/metabolism , DNA, Complementary/genetics , Dipeptides/metabolism , Endopeptidases/pharmacology , Enzyme Activation/drug effects , Enzyme Precursors/biosynthesis , Enzyme Precursors/pharmacology , Mice , Microscopy, Phase-Contrast , Mitogens/metabolism , Mitogens/pharmacology , Point Mutation , Prothrombin/biosynthesis , Prothrombin/pharmacology , Rats , Rats, Wistar , Receptors, Thrombin/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Thrombin/metabolism , Thrombin/pharmacology
6.
Protein Expr Purif ; 10(2): 214-25, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9226718

ABSTRACT

A human prothrombin cDNA has been engineered to obtain a cDNA coding for a secreted form of human prethrombin-2. The secreted prethrombin-2 has been produced in a mammalian expression system using DXB11 cells, a mutant strain of CHO cells in which the dihydrofolate reductase gene has been deleted, and an expression vector carrying the dihydrofolate reductase cDNA. Methotrexate-induced gene amplification favored an efficient production of the recombinant protein which accumulated in the culture medium of the DXB11 cells. Growth in suspension of the stable transformants in an airlift fermenter resulted in the production of 25 mg/L recombinant prethrombin-2. The recombinant protein was purified using single-step affinity chromatography on a recombinant-hirudin column and activated by agarose gel-immobilized ecarin. All purified recombinant prethrombin-2 was activated and the generated recombinant thrombin showed catalytic properties identical to those of plasma-derived alpha-thrombin. This expression system can be used to prepare mutants of prethrombin-2 for structure-function studies investigating thrombin interactions with substrate proteins, inhibitors, and cell membranes.


Subject(s)
Enzyme Precursors/biosynthesis , Enzyme Precursors/isolation & purification , Prothrombin/biosynthesis , Prothrombin/isolation & purification , Thrombin/metabolism , Animals , CHO Cells , Cricetinae , Enzyme Precursors/genetics , Enzyme Precursors/metabolism , Genetic Vectors , HeLa Cells , Humans , Mass Spectrometry , Prothrombin/genetics , Prothrombin/metabolism , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Sequence Analysis , Transformation, Genetic
7.
J Biol Chem ; 272(8): 5229-35, 1997 Feb 21.
Article in English | MEDLINE | ID: mdl-9030593

ABSTRACT

The human ribosomal protein L7a is a component of the major ribosomal subunit. We transiently expressed in HeLa cells L7a-beta-galactosidase fusion proteins and studied their subcellular localization by indirect immunofluorescence staining with anti-beta-galactosidase antibodies. We have identified three distinct domains responsible for the nuclear targeting of the protein: domain I, amino acids 23-51; domain II, amino acids 52-100; domain III, amino acids 101-220, each of which contains at least one nuclear localization signal (NLS). Through subcellular localization analysis of deletion mutants of L7a-beta-galactosidase chimeras, we demonstrate that domain II plays a special role because it is necessary, although not sufficient, to target the chimeric beta-galactosidase to the nucleoli. In fact, we demonstrate that the nucleolar targeting process requires the presence of domain II plus an additional basic domain that can be represented by an NLS or a basic stretch of amino acids without NLS activity. Thus, when multiple NLS are present, each NLS exerts distinct functions. Domain II drives nucleolar accumulation of a reporter protein with the cooperative action of a short basic amino acid sequence, suggesting a mechanism requiring protein-protein or protein-nucleic acid interactions.


Subject(s)
Cell Nucleolus/metabolism , Cell Nucleus/metabolism , Ribosomal Proteins/metabolism , Amino Acid Sequence , Biological Transport , Cell Line , Humans , Molecular Sequence Data , Plasmids , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Ribosomal Proteins/genetics
8.
Gene ; 126(2): 227-35, 1993 Apr 30.
Article in English | MEDLINE | ID: mdl-8482538

ABSTRACT

A cDNA coding for the human L7a ribosomal protein (r-protein) was used to isolate the corresponding gene by screening two human genomic libraries constructed in bacteriophage lambda and in a cosmid vector. One of the cosmid clones isolated, cos1.1, contains the whole L7 alpha gene, composed of eight exons and seven introns spanning 3226 bp. As in other mammalian housekeeping genes, the promoter and the first exon of the L7 alpha reside within a CpG-rich island. Furthermore, similar to the other higher eukaryote r-protein-encoding genes characterized so far, the human L7 alpha gene has a C as the major transcriptional start point localized in a pyrimidine-rich region and lacks a canonical TATA sequence. We show that 130 bp of the human L7 alpha gene 5'-flanking region represent the minimal element required to promote its transcription. This element is strikingly conserved between the mouse and human L7 alpha genes. Finally, a comparison of the human L7 alpha gene coding sequence and the predicted amino acid (aa) sequence with the sequences of mouse L7a, rat L7a, and the homologous yeast L4 shows that the aa sequence has been highly conserved during evolution.


Subject(s)
Ribosomal Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Biological Evolution , Cloning, Molecular , DNA , Dinucleoside Phosphates/analysis , Gene Expression Regulation , Humans , Mice , Molecular Sequence Data , Regulatory Sequences, Nucleic Acid , Restriction Mapping , Ribosomal Proteins/metabolism , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid
9.
Eur J Biochem ; 208(1): 23-30, 1992 Aug 15.
Article in English | MEDLINE | ID: mdl-1324834

ABSTRACT

The availability of engineered serine proteases allows one to study the activation, substrate specificity and regulation of human coagulation and fibrinolytic activities. Human coagulation factor XII is composed of the protease catalytic region at the C-terminus, a hinge proline-rich region and regulatory domains at the N-terminus. From cDNA clones coding for factor XII, two DNA molecules were constructed, one being full length and the other being deleted of exons coding for the regulatory domains. Engineered factor-XII cDNA species were inserted by a homologous recombination technique into vaccinia viruses, which were used to infect the human hepatoma cell line HepG2. Two recombinant proteins were prepared from the culture media and identified by their antigenic properties and electrophoretic mobilities. The recombinant protein of larger size was identified as the full-length factor XII of 80 kDa and its specific activities and activation patterns, determined both by the coagulation and the amidolytic assays, are very similar to these of native human factor XII. The recombinant protein of smaller size was identified as a 319-amino-acid-deleted factor-XII protein of 32 kDa, containing only the entire protease region and part of the proline-rich hinge. This protein was expected to be the 'minimal' portion of factor XII able to sustain protease but unable to recognize substrates and surfaces necessary to activate the contact phase of coagulation. However, this 'minimal' factor-XII protein displays a marked protease activity and, although lacking five regulatory domains of factor XII, is bound and activated by negative charges and promotes coagulation with high efficiency.


Subject(s)
Blood Coagulation/physiology , Chromosome Deletion , Factor XII/metabolism , Recombinant Proteins/metabolism , Serine Endopeptidases/metabolism , Base Sequence , Binding Sites , Carcinoma, Hepatocellular , Cell Line , Cloning, Molecular , DNA/genetics , Factor XII/genetics , Gene Library , Humans , Kinetics , Liver Neoplasms , Molecular Sequence Data , Oligodeoxyribonucleotides , Protein Engineering , Restriction Mapping , Serine Endopeptidases/genetics
10.
Biotechnol Appl Biochem ; 14(2): 222-33, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1662049

ABSTRACT

Several systems have been devised that are based on viral promoters suitable for gene expression in eukaryotic cells. One such system, vaccinia virus, has been successfully used to express a variety of heterologous proteins following the construction of a recombinant virus. Indeed, because of the ability of vaccinia virus to infect a wide range of host cells, the expression system can be custom-designed so that a cell line can be instrumental in ensuring the correct processing of the recombinant polypeptide. We show that recombinant vaccinia virus and human hepatoma cells in culture are an efficient expression system with which to produce correctly modified and biologically active human prothrombin (15 micrograms/10(7) cells) and antithrombin III (40 micrograms/10(7) cells).


Subject(s)
Antithrombin III/genetics , Genetic Vectors , Prothrombin/genetics , Vaccinia virus/genetics , Animals , Antithrombin III/metabolism , Blotting, Western , Carcinoma, Hepatocellular , Cell Line , Cloning, Molecular , Humans , Prothrombin/metabolism , Rabbits , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Tumor Cells, Cultured
11.
Cell ; 57(3): 469-81, 1989 May 05.
Article in English | MEDLINE | ID: mdl-2541915

ABSTRACT

The CD4 molecule is a T cell surface glycoprotein that interacts with high affinity with the envelope glycoprotein of the human immunodeficiency virus, HIV, thus serving as a cellular receptor for this virus. To define the sites on CD4 essential for binding to gp120, we produced several truncated, soluble derivatives of CD4 and a series of 26 substitution mutants. Quantitative binding analyses with the truncated proteins demonstrate that the determinants for high affinity binding lie solely with the first 106 amino acids of CD4 (the V1 domain), a region having significant sequence homology to immunoglobulin variable regions. Analysis of the substitution mutants further defines a discrete binding site within this domain that overlaps a region structurally homologous to the second complementarity-determining region of antibody variable domains. Finally, we demonstrate that the inhibition of virus infection and virus-mediated cell fusion by soluble CD4 proteins depends on their association with gp120 at this binding site.


Subject(s)
Antigens, Differentiation, T-Lymphocyte/analysis , HIV/metabolism , Acquired Immunodeficiency Syndrome/genetics , Amino Acid Sequence , Antigen-Presenting Cells/immunology , Antigens, Differentiation, T-Lymphocyte/genetics , Antigens, Differentiation, T-Lymphocyte/metabolism , Binding Sites , Gene Expression Regulation , HIV Envelope Protein gp120 , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mutation , Receptors, HIV , Receptors, Virus/metabolism , Retroviridae Proteins/metabolism , T-Lymphocytes/immunology
12.
Cancer Res ; 41(4): 1565-71, 1981 Apr.
Article in English | MEDLINE | ID: mdl-6260344

ABSTRACT

The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the sarc protein kinase of normal chick embryo fibroblasts (CEF) and of the src kinase of cells transformed by a temperature-sensitive mutant of avian sarcoma virus (CEF-tsASV) were studied and compared with the known effects of TPA on cell morphology and plasminogen activator (PA) activity. One hr after the addition of TPA to normal CEF, there was a 3- to 8-fold stimulation of kinase activity when compared to control cultures; during the subsequent 24 hr, TPA produced less than a 2-fold stimulation. Although TPA induced levels of PA in CEF which were equivalent to those produced by cEF-tsASV grown at 36 degrees, the latter cells contained much higher levels of kinase activity than those of CEF plus TPA. In addition, TPA failed to enhance the kinase activity of CEF-tsASV at either 36 degrees or 40 degrees, even though at both temperatures TPA induced morphological changes and markedly enhanced PA activity. These results suggest that the effects of TPA on morphology and PA are not due to an effect on these protein kinases.


Subject(s)
Avian Sarcoma Viruses/genetics , Cell Transformation, Viral , Phorbol Esters/pharmacology , Phorbols/pharmacology , Protein Kinases/genetics , Animals , Cell Transformation, Neoplastic/chemically induced , Cells, Cultured , Chick Embryo , Mutation , Phenotype , Plasminogen Activators/metabolism , Protein Kinases/metabolism , Temperature
13.
Cancer Res ; 40(9): 3369-73, 1980 Sep.
Article in English | MEDLINE | ID: mdl-6159074

ABSTRACT

Tumor-promoting agents are known to inhibit the specific differentiation processes of several animal cell systems in vitro, including the Friend leukemia cell system. We have examined the effect of 12-O tetradecanoylphorbol-13-acetate (TPA) on the latter system and have investigated its action on Friend virus expression. At a concentration of 16.7 nM, TPA inhibits the dimethyl sulfoxide-induced Friend cell terminal differentiation and, at the same time, enhances the expression of the Friend virus genome, as demonstrated by a 2-fold increase in the amount of reverse transcriptase-containing particles released into the culture fluid and in the levels of virus-specific intracytoplasmic RNA. The greatest effect of TPA is evident after 24 hr of treatment. At this time, TPA exerts also its strongest effect upon the induction of the plasminogen activator. Our results indicate that two specific effects of TPA, i.e., block of differentiation and induction of plasminogen activator, correlate well in the Friend cell system with an extracellular and intracellular increase in virus expression.


Subject(s)
Friend murine leukemia virus/genetics , Genes, Viral/drug effects , Leukemia, Erythroblastic, Acute/metabolism , Phorbols/pharmacology , RNA, Viral/metabolism , RNA-Directed DNA Polymerase/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Cell Differentiation/drug effects , Clone Cells , Dimethyl Sulfoxide , Friend murine leukemia virus/drug effects , Friend murine leukemia virus/enzymology , Neoplasms, Experimental/metabolism , Plasminogen Activators/metabolism
14.
Enzyme ; 25(2): 92-6, 1980.
Article in English | MEDLINE | ID: mdl-6445825

ABSTRACT

A study was made of the behavior of the phosphoglucomutase (PGluM) and creatine phosphokinase (CPK) in the liver tissue of guinea pigs after chronic digitalis intoxication. It was found that the latter causes a statistically significant decrease of both enzymatic activities. The results obtained by the authors with this investigation, together with those of previous researchers, show that the toxic effect of digitalis on the enzymatic activities is not limited to the reported effect on the ATPase but also involves, at least at the doses and under the conditions used, other enzymatic activities.


Subject(s)
Creatine Kinase/metabolism , Digitalis Glycosides/poisoning , Liver/enzymology , Phosphoglucomutase/metabolism , Animals , Guinea Pigs
16.
Int J Cancer ; 20(5): 738-47, 1977 Nov 15.
Article in English | MEDLINE | ID: mdl-200573

ABSTRACT

Fucose-labelled glycopeptides obtained from the cell surfaces of normal and transformed epithelial cells were compared by co-chromatography on Sephadex G-50. The material obtained from epithelial cells transformed in vitro or from hepatoma cells in culture elutes earlier than the fucose-containing glycopeptides obtained from normal rat epithelial cells. A mutant (TS 223) of a transformed epithelial cell that is temperature-sensitive for maintenance of the transformed phenotype, varies in its Sephadex G-50 profile of cell surface glycopeptides when grown at the permissive (36 degrees C) or the non-permissive temperature (40 degrees C). When grown and labelled at 36 degrees C the gel filtration profile of the glycopeptides resembles that of transformed cells. At 40 degrees C there is an enrichment of later eluting glycopeptides. These differences are more striking in confluent-phase cultures than in log-phase culture. The differences are reversible following upward or downward shifts in growth temperature although there appears to be a lag of at least 6 h before the alteration can be demonstrated by these procedures.


Subject(s)
Cell Line , Cell Transformation, Neoplastic , Epithelial Cells , Glycopeptides/analysis , Animals , Carcinoma, Hepatocellular/analysis , Cell Membrane/analysis , Chromatography, Gel , Liver Neoplasms/analysis , Mutation , Neoplasms, Experimental/analysis , Phenotype , Rats , Temperature
17.
Boll Ist Sieroter Milan ; 56(3): 282-7, 1977 Jul 31.
Article in Italian | MEDLINE | ID: mdl-901641

ABSTRACT

Neutralizing antibody activity against Coxsackie virus group B, types 1-6, was determined on paired serum samples taken from 16 hospitalized patients affected by acute heart diseases of suspected viral origin. Serum samples were also taken from 4 additional cases of pleuropericarditis observed in the course of a small outbreak of Coxsackie B2 infection. Serological evidence of virus infection was based on the occurrence of the following conditions: a) twofold or greater variation of virus neutralizing antibody; b) antibody titers equal to or greater than 1:256. Evidence of Coxsackie B2 virus infection was found in 12 patients, while Coxsackievirus B1, B3, B5 and B6 infection, respectively, could be associated with 4 cases. The advisability of performing serological examination for Coxsackie group B viruses antibodies in patients with heart diseases of suspected viral origin is emphasized.


Subject(s)
Coxsackievirus Infections/complications , Myocardial Infarction/etiology , Myocarditis/etiology , Pericarditis/etiology , Adolescent , Adult , Antibodies, Viral/analysis , Coxsackievirus Infections/diagnosis , Female , Humans , Male , Middle Aged
18.
Cancer Res ; 35(8): 2191-8, 1975 Aug.
Article in English | MEDLINE | ID: mdl-238738

ABSTRACT

Several carcinogens are bound covalently to cellular nucleic acids. This is also the case with polycyclic hydrocarbon carcinogens, but their precise mechanism of in vivo activation to reactive forms and the structure(s) of the nucleic acid adducts are not known. This study demonstrates that in the presence of rat liver microsomes and reduced nicotinamide adenine dinucleotide phosphate there is covalent attachment of tritiated benzo(a)pyrene (BP) to transfer RNA, DNA, certain synthetic polyribonucleotides, and an RNA species endogenous to the microsomal fraction. Evidence has been obtained that the binding occurs mainly to guanine and, to a lesser extent, adenine residues and is not simple an artifact of tritium exchange. The microsomal-mediated binding of [3H]BP to nucleic acids requires reduced nicotinamide adenine dinucleotide phosphate and in inhibited by 7,8-benzoflavone, glutathione, and magnesium. It is enhanced somewhat by the addition of styrene oxide, cyclohexene oxide, and trichloropropylene oxide. These results provide the first evidence that: (a) the microsome-mediated binding of [3H]BP to nucleic acids is not just due to tritium exchange; (b) a derivative of the hydrocarbon is covalently bound to the nucleic acid, and not simply intercalated; (c) there is a preferential binding to guanine residues; and (d) in addition to binding to exogenous nucleic acids, [3H]BP is bound to an RNA species present in the microsomes. Our data are consistent with but do not prove that nucleic acid binding of this polycyclic hydrocarbon proceeds via an epoxide intermediate.


Subject(s)
Benzopyrenes/metabolism , Microsomes, Liver/metabolism , Nucleic Acids/metabolism , 9,10-Dimethyl-1,2-benzanthracene/pharmacology , Animals , Binding Sites , Centrifugation, Density Gradient , Chemical Phenomena , Chemistry , Chromatography, Ion Exchange , DNA/analysis , DNA/metabolism , Depression, Chemical , Dose-Response Relationship, Drug , Flavonoids/pharmacology , Glutathione/pharmacology , Guanine Nucleotides/metabolism , Kinetics , Magnesium/pharmacology , Male , Methylcholanthrene/pharmacology , Models, Biological , NADP/metabolism , RNA, Transfer/metabolism , Rats , Saccharomyces cerevisiae , Stimulation, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...